about
Comprehensive drug screening by integrated use of gas chromatography/mass spectrometry and Remedi HS.Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.MAM-2201 (analytically confirmed) intoxication after "Synthacaine" consumption.Behavioral responses to acute and sub-chronic administration of the synthetic cannabinoid JWH-018 in adult mice prenatally exposed to corticosterone.Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy.Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levelsIllicit drugs in Emergency Department patients injured in road traffic accidentsAnalytically diagnosed intoxication by 2-methoxphenidine and flubromazepam mimicking an ischemic cerebral disease
P50
Q30989686-3F7D83FB-C9D9-4A06-9B1E-A84121383FCBQ42619331-8E105BD1-0FD9-4313-ADC6-30EA359B38BAQ47912259-A8E64EA7-7AD6-4523-ACE8-1F95F4E58A35Q50542166-506E2E92-EF6E-4EAA-B787-DA12C4B442BFQ54526459-1FCA9D76-8B06-44F9-8AFF-6458E22389C0Q80414444-40C1821A-A01B-491A-8ADF-06216FF173BBQ87713470-6CC51F47-341A-4EFC-BD30-2D557B493A5FQ87942155-E9275BD6-C3CD-4B3F-862A-0289C9F8C866
P50
description
researcher
@en
name
A Valli
@en
A Valli
@nl
type
label
A Valli
@en
A Valli
@nl
prefLabel
A Valli
@en
A Valli
@nl
P106
P31
P496
0000-0002-6181-2892